InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-26.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Falconer Ester, Chief Technology Officer. Officer active across 1 company, notably AbCellera Biologics Inc.. Aggregated, 4 filings have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €41.9m. History available since 9 June 2021. The latest transaction was disclosed on 1 September 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
875,000 shares@ US$16.891.00% mcap18.7% of flowCommon SharesSEC:0001209191-21-054749:0
875,000 shares@ US$16.8918.7% of flowCommon SharesSEC:0001209191-21-054749
1,000,000 shares@ US$25.501.68% mcap31.3% of flowCommon SharesSEC:0000899243-21-022987:0
1,000,000 shares@ US$25.5031.3% of flowCommon SharesSEC:0000899243-21-022987
4 of 4 declarations
About Falconer Ester
Ester Falconer is the Chief Technology Officer at AbCellera Biologics Inc., a company specializing in the development of biological therapies. In her role, she is responsible for technological innovation and research and development strategy, ensuring that AbCellera remains at the forefront of innovation in its field.
